Abstract
The correlation of new biomarkers with In patients with coronary artery disease (CAD), left ventricular ejection fraction.Globally, coronary artery disease is a significant non-communicable disease issue. Numerous significant risk factors, including smoking, diabetes mellitus, dyslipidemia, and hypertension, can result in coronary artery disease. [1]. patient heart failure management. When following up on heart failure cohorts over an extended period of time, plasma BNP or NT-proBNP is a highly effective independent predictor of death and morbidity. Furthermore, it seems to be a reliable indicator of a positive reaction when beta blocker is added to anti-heart failure medication. When changing therapy for heart failure based on serial measures of NT-proBNP, as opposed to altering therapy based on independent clinical judgment, better results are expected.
Article Type
Article
Recommended Citation
Alhussainy, Ola Muslim; ALammar, Haider Abd Jabbar; and Hassan, Aqeel Raheem
(2026)
"Relevance of GADF15 biomarker with left ventricular ejection fraction in coronary artery disease (CAD ) patients,"
Al-Qadisiyah Medical Journal: Vol. 20:
Iss.
2, Article 5.
Available at:
https://qmj.researchcommons.org/journal/vol20/iss2/5
First Page
85
Last Page
89
Rights
Copyright (c) 2024 2024
